Funding Opportunities

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

Request for Application Release and Peer Review Schedule
Financial Years 2014 & 2015
Product Development Programs
Review Cycle Award Mechanism
Request for Application
RFA Release Application Receipt Application Review Award Notification
Financial Year 2015 - Cycle 3 Company Relocation Product Development Awards
Revised: (07/31/2014)

This award mechanism seeks to support companies or limited partnerships that are willing to relocate to Texas to develop new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap. Companies must have at least one round of professional institutional investment.

Award: No maximum amount; Maximum duration of 36 months.

Jul 21, 2014 Aug 25-
Sep 29, 2014
Continuous May 2015
Financial Year 2014 - Cycle 3 Established Company Product Development Awards
Revised: (07/31/2014)

This award mechanism seeks to fund the research and development of innovative products, services, and infrastructure with significant potential impact on patient care. Companies must have at least one round of professional institutional investment, and must be headquartered in Texas. The proposed project must further the development of new products for the diagnosis, treatment, or prevention of cancer; must establish infrastructure that is critical to the development of a robust industry; or must fill a treatment or research gap.

Award: No maximum amount; Maximum duration of 36 months.

Jul 21, 2014 Aug 25-
Sep 29, 2014
Continuous May 2015
Financial Year 2015 - Cycle 3 New Company Product Development Awards
Revised: (07/31/2014)

This award mechanism seeks to support early-stage “start-up” companies in the research and development of new products for the diagnosis, treatment, or prevention of cancer. Companies must have a significant presence in Texas or be willing to relocate to Texas.

Award: No maximum amount; Maximum duration of 36 months.

Jul 21, 2014 Aug 25-
Sep 29, 2014
Continuous May 2015
Financial Year 2015 - Cycle 2 Bridging the Gap: Early Translational Research Awards

Supports projects that "bridge the gap" between promising new discoveries achieved in the research laboratory and commercial development for a therapeutic, device, or diagnostic assay through activities up to and including preclinical proof-of-principle data that demonstrate applicability to the planned clinical scenario. Any not-for-profit institution that conducts research is eligible to apply for funding under this award mechanism; a public or private company is not eligible.

Award: Up to $2 million in total costs over a period of 1-3 years. Exceptions permitted if extremely well justified.

May 23, 2014 Jun 26-
Aug 7, 2014
Oct 2014 Nov 2014
Financial Year 2015 - Cycle 1

CLOSED
Company Relocation Product Development Awards
Revised: (05/16/2014)

This award mechanism seeks to support companies or limited partnerships that are willing to relocate to Texas to develop new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap. Companies must have at least one round of professional institutional investment.

Award: No maximum amount; Maximum duration of 36 months.

Mar 31, 2014 Apr 28-
May 29, 2014
Continuous Nov 2014
Financial Year 2015 - Cycle 1

CLOSED
Established Company Product Development Awards
Revised: (05/16/2014)

This award mechanism seeks to fund the research and development of innovative products, services, and infrastructure with significant potential impact on patient care. Companies must have at least one round of professional institutional investment, and must be headquartered in Texas.

Read more...

Mar 31, 2014 Apr 28-
May 29, 2014
Continuous Nov 2014
Financial Year 2015 - Cycle 1

CLOSED
New Company Product Development Awards
Revised: (05/16/2014)

This award mechanism seeks to support early-stage “start-up” companies in the research and development of new products for the diagnosis, treatment, or prevention of cancer. Companies must have a significant presence in Texas or be willing to relocate to Texas.

Award: No maximum amount; Maximum duration of 36 months.

Mar 31, 2014 Apr 28-
May 29, 2014
Continuous Nov 2014
Research Programs
Review Cycle Award Mechanism
Request for Application
RFA Release Application Receipt Application Review Award Notification
Financial Year 2015 - Cycle 2 Multi-Investigator Research Awards (MIRA)

Multi-Investigator Research Awards are intended to support the creation of integrated programs of collaborative and cross-disciplinary research among multiple investigators. These should be equivalent to program projects, research centers, NCI SPOREs, multi-institutional clinical trial networks, or other types of collaborative interactions.

Read more...

Jul 24, 2014 Sep 30-
Nov 17, 2014
Dec 2014-
Mar 2015
May 2015
Financial Year 2015 - Cycle 1 High-Impact/High-Risk Research Awards (HIHR)

The Cancer Prevention and Research Institute of Texas (CPRIT) seeks applications from eligible organizations for the High-Impact, High-Risk Research Awards grant mechanism to provide short-term funding to explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis, treatment, or prevention of cancers.

Read more...

Jul 14, 2014 Sep 30-
Nov 17, 2014
Dec 2014-
Mar 2015
May 2015
Financial Year 2015 - Cycle 1 Core Facility Support Awards (CFSA)
Revised: (07/23/2014)

Supports the establishment or enhancement of core research facilities (laboratory based or clinical) that will provide valuable services to enhance the outcomes of scientifically meritorious cancer research projects. Award: Up to $2M (total costs) for the first year, and up to $1M (total costs) for subsequent years. Maximum duration of 5 years.

Jul 14, 2014 Sep 30-
Nov 17, 2014
Dec 2014-
Mar 2015
May 2015
  Recruitment of First-Time, Tenure-Track Faculty Members
Revised: (07/25/2014)

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research. Award: Up to $2 million over a period of 4 years.

Guidance to Offices Preparing Recruitment Nominations

Jun 10, 2014 Jun 12-
Aug 29, 2014
Continuous Continuous
  Recruitment of Rising Stars

Recruits outstanding early-stage investigators to Texas, who have demonstrated the promise for continued and enhanced contributions to the field of cancer research. Award: Up to $4 million over a period of 5 years.

Guidance to Offices Preparing Recruitment Nominations

Jun 10, 2014 Jun 12-
Aug 29, 2014
Continuous Continuous
  Recruitment of Established Investigators
Revised: (07/25/2014)

Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas. Award: Up to $6M over a period of five years.

Guidance to Offices Preparing Recruitment Nominations

Jun 10, 2014 Jun 12-
Aug 29, 2014
Continuous Continuous
CLOSED Recruitment of First-Time, Tenure-Track Faculty Members
Revised: (03/31/2014)

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research. Award: Up to $2 million over a period of 4 years.

Guidance to Offices Preparing Recruitment Nominations

Jan 15, 2014 Apr 1-
Jun 11, 2014
Continuous Continuous
CLOSED Recruitment of Rising Stars
Revised: (03/31/2014)

Recruits outstanding early-stage investigators to Texas, who have demonstrated the promise for continued and enhanced contributions to the field of cancer research. Award: Up to $4 million over a period of 5 years.

Guidance to Offices Preparing Recruitment Nominations

Jan 14, 2014 Apr 1-
Jun 11, 2014
Continuous Continuous
CLOSED Recruitment of Established Investigators
Revised: (03/31/2014)

Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas. Award: Up to $6M over a period of five years.

Guidance to Offices Preparing Recruitment Nominations

Jan 15, 2014 Apr 1-
Jun 11, 2014
Continuous Continuous
Financial Year 2015 - Cycle 1

CLOSED
Individual Investigator Research Awards
Revised: (05/13/2014)

Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Areas of interest include laboratory research, translational studies, and/or clinical investigations. Competitive renewal applications accepted.

Award: Up to $300,000 per year. Exceptions permitted if extremely well justified; Maximum duration: 3 years.

Mar 31, 2014 May 15-
Jun 26, 2014
Oct-Nov 2014 Jan 2015
Financial Year 2015 - Cycle 1

CLOSED
Individual Investigator Research Awards for Prevention and Early Detection
Revised: (05/13/2014)

Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, early-stage progression, and/or early detection of cancer. Research may be laboratory-, clinical-, or population- based, and may include behavioral/intervention, dissemination or health services/outcomes research to reduce cancer incidence or promote early detection.

Read more...

Mar 31, 2014 May 15-
Jun 26, 2014
Oct-Nov 2014 Jan 2015
Financial Year 2015 - Cycle 1

CLOSED
Individual Investigator Research Awards for Cancer in Children and Adolescents
Revised: (05/13/2014)

Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable.

Read more...

Mar 31, 2014 May 15-
Jun 26, 2014
Oct-Nov 2014 Jan 2015
Financial Year 2014 - Cycle 1

CLOSED
High-Impact/High-Risk Research Awards (HIHR)

The Cancer Prevention and Research Institute of Texas (CPRIT) seeks applications from eligible organizations for the High-Impact, High-Risk Research Awards grant mechanism to provide short-term funding to explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis, treatment, or prevention of cancers.

Read more...

Dec 9, 2013 Dec 2013-Feb 2014 Apr-Jun 2014 Aug 2014
Financial Year 2014 - Cycle 1

CLOSED
Multi-Investigator Research Award Continuation Grants for Years 4 and 5
Revised: (01/03/2014)

The Cancer Prevention and Research Institute of Texas (CPRIT) seeks applications from eligible organizations to continue the Multi-Investigator Research Award (MIRA) Continuation Grants for Years 4 and 5 to support integrated programs of collaborative and cross-disciplinary research among multiple investigators and focus on critical research areas that contribute meaningfully to advancing knowledge of the causes, prevention, and/or treatment of cancer. This award mechanism is open only to programs funded in 2010 pursuant to RFA R-10-MIRA1.

Read more...

Dec 16, 2013 Dec 2013-Jan 2014 Feb 2014 Feb 2014
Financial Year 2014 - Cycle 1

CLOSED
Research Training Award Continuation Grants for Years 4 and 5

The Cancer Prevention and Research Institute of Texas (CPRIT) seeks applications from eligible organizations to continue the integrated institutional Research Training Awards (RTA) for Years 4 and 5 to support promising individuals who seek specialized training in the area of cancer research. This award mechanism is open only to programs funded in 2010 pursuant to RFA R-10-RTA1.

Read more...

Dec 9, 2013 Dec 2013-Jan 2014 Feb 2014 Feb 2014
Prevention Programs
Review Cycle Award Mechanism
Request for Application
RFA Release Application Receipt Application Review Award Notification
Financial Year 2015 - Cycle 1

CLOSED
Evidence-Based Cancer Prevention Services

This award mechanism seeks to fund programs that greatly challenge the status quo in the delivery of evidence-based cancer prevention and control clinical services and that propose to serve areas of the state not well addressed by current CPRIT funded projects.

Award: Maximum of $1.5M; Maximum duration of 36 months.

Mar 31, 2014 Apr 29-
Jul 10, 2014
Sep-Oct 2014 Nov 2014
Financial Year 2015 - Cycle 1

CLOSED
Competitive Continuation/Expansion Projects

This RFA solicits grant applications from qualified organizations located in the State of Texas that propose to continue or expand highly successful projects previously or currently funded by CPRIT. This award mechanism is open only to previously or currently funded CPRIT prevention projects.

Read more...

Mar 31, 2014 Apr 29-
Jul 10, 2014
Sep-Oct 2014 Nov 2014
Financial Year 2014 - Cycle 1

CLOSED
Competitive Continuation/Expansion Projects
Revised: (01/15/2014)
Revised: (01/15/2014)

This RFA solicits grant applications from qualified organizations located in the State of Texas that propose to continue or expand highly successful projects previously or currently funded by CPRIT. This award mechanism is open only to previously or currently funded CPRIT prevention projects.

Read more...

Dec 9, 2013 Dec 2013-Feb 2014 Mar-Jun 2014 Aug 2014
Financial Year 2014 - Cycle 1

CLOSED
Evidence-Based Cancer Prevention Services
Revised: (01/15/2014)
Revised: (01/15/2014)

This RFA solicits grant applications from qualified organizations located in the State of Texas that propose to deliver evidence-based services in at least one of the following cancer prevention and control areas: 1) Primary cancer prevention (e.g. vaccine-conferred immunity, tobacco cessation ...

Read more...

Dec 9, 2013 Dec 2013-Feb 2014 Mar-Jun 2014 Aug 2014
Financial Year 2014 - Cycle 1

CLOSED
Health Behavior Change Through Public Education
Revised: (01/15/2014)
Revised: (01/15/2014)

This RFA solicits grant applications from qualified organizations located in the State of Texas that propose health promotion, education, and outreach for prevention, early detection, and survivorship of cancer for the public that, ...

Read more...

Dec 9, 2013 Dec 2013-Feb 2014 Mar-Jun 2014 Aug 2014